FDA Warning Letters

Covers major FDA compliance actions, analysis of warning letters, common pitfalls.

January 17, 2024
Takeaway -

Inflammation + arthritis claims = warning letter

January 10, 2024
Takeaway -

Old blogs & posts are “active” marketing

January 3, 2024
Takeaway -

Product tags are marketing claims

December 27, 2023
Takeaway -

Distributors are responsible for products they sell

December 20, 2023
Takeaway -

Review old videos for compliance

December 13, 2023
Takeaway -

Review old social posts for regulatory “landmines”

November 29, 2023
Takeaway -

Companies are responsible for co-manufactured products

November 22, 2023
Takeaway -

Influencers must disclose material connection

November 15, 2023
Takeaway -

Re-review online marketing after FDA inspection

November 1, 2023
Takeaway -

Ensure ingredients are GRAS for the marketed population